C

Alcon Inc. ALC

$74.12 $2.293.19% NYSE
Recommendation
Dividend Power Score
Day's Range
$72.58$74.18
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

ALC Rating

Reward
Risk

ALC Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

ALC Company Overview

Alcon Inc. is a global eye care company focused on surgical and vision care products for ophthalmologists, optometrists, and consumers. The company operates primarily in the medical technology and healthcare industries, with products spanning cataract surgery, refractive surgery, vitreoretinal surgery, contact lenses, ocular health products, and related digital vision technologies. Revenue is principally generated through sales of consumable surgical products, implantable intraocular lenses, contact lenses, and over-the-counter eye care solutions. Public disclosures and industry reporting identify the company as one of the largest dedicated eye care businesses globally.

Alcon traces its origins to a pharmacy established in Texas in 1945 and later evolved into a specialized ophthalmic products manufacturer. The company became part of Nestlé in the late 1970s before being acquired by Novartis in stages between 2008 and 2011. In 2019, Alcon was spun off from Novartis and began operating as an independent publicly traded company listed on the SIX Swiss Exchange and the New York Stock Exchange. The company’s strategic positioning is supported by its global ophthalmic distribution network, recurring consumables revenue base, extensive surgeon relationships, and broad portfolio across both surgical and vision care categories.

Data compiled by narrative technology. May contain errors.
Sector

ALC Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

ALC Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

ALC Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

ALC Price History

Loading...
52-Week Range48% of range
Current
$74.12
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

ALC Valuation

Market Cap
Market Cap Rank
#924
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

ALC Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

ALC Corporate Info

Phone Number
41 589 112 110
Address
Chemin de Blandonnet 8
Vernier
Geneva, 1214
Country
Year Founded

ALC Filings

Filing Date
Tuesday, November 10, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

ALC Headlines

11/11/2026 - Nasdaq News: Markets
11/11/2026 - Fool.com Headlines
11/10/2026 - Seeking Alpha - Healthcare
11/10/2026 - Nasdaq News: Markets